A1CF anticorps (N-Term)
Aperçu rapide pour A1CF anticorps (N-Term) (ABIN633343)
Antigène
Voir toutes A1CF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- A1 CF antibody was raised against the N terminal of A1 F
-
Purification
- Affinity purified
-
Immunogène
- A1 CF antibody was raised using the N terminal of A1 F corresponding to a region with amino acids MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQENGQRKYGGPPPGWDAA
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
A1CF Blocking Peptide, (ABIN5611834), is also available for use as a blocking control in assays to test for specificity of this A1CF antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of A0 F antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- A1CF (APOBEC1 Complementation Factor (A1CF))
-
Autre désignation
- A1CF
-
Sujet
- Mammalian apolipoprotein B mRNA undergoes site-specific C to U deamination, which is mediated by a multi-component enzyme complex containing a minimal core composed of APOBEC-1 and a complementation factor encoded by this gene.
-
Poids moléculaire
- 64 kDa (MW of target protein)
Antigène
-